Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report)’s share price fell 75.6% during trading on Thursday . The company traded as low as $0.82 and last traded at $1.25. 44,974,361 shares changed hands during mid-day trading, an increase of 2,077,238% from the average session volume of 2,165 shares. The stock had previously closed at $5.12.
Graybug Vision Stock Down 75.6%
The stock has a fifty day moving average of $5.08 and a 200-day moving average of $3.76. The firm has a market capitalization of $1.96 million, a P/E ratio of -0.72 and a beta of 1.20.
Graybug Vision Company Profile
Graybug Vision, Inc is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for retinal diseases. The company’s proprietary Depot Technology Platform is designed to deliver sustained-release formulations of biologically active agents directly to the back of the eye, with the goal of reducing treatment burden and improving patient outcomes. Graybug’s lead product candidate, GB-102, is a long-acting formulation of sunitinib malate being investigated for the treatment of wet age-related macular degeneration (wet AMD).
Featured Stories
- Five stocks we like better than Graybug Vision
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- Nvidia CEO Issues Bold Tesla Call
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
